# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Trupanion, Inc. (NASDAQ:TRUP), the leading global provider of medical insurance for cats and dogs, announced today the official...
Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advis...
Northland Capital Markets analyst Greg Gibas maintains Trupanion (NASDAQ:TRUP) with a Market Perform and raises the price ta...
Piper Sandler analyst John Barnidge maintains Trupanion (NASDAQ:TRUP) with a Neutral and raises the price target from $30 to...
Stifel analyst Jonathan Block reiterates Trupanion (NASDAQ:TRUP) with a Hold and raises the price target from $22 to $30.
Trupanion (NASDAQ:TRUP) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.18) by ...
William Blair analyst Brandon Vazquez initiates coverage on Trupanion (NASDAQ:TRUP) with a Outperform rating.